Targeting human CLEC9A+ dendritic cells as a new strategy for cancer immunotherapy (2015–2017)
- Grant type:
- Worldwide Cancer Research
- Researchers:
-
-
Honorary Professor
Mater Research Institute-UQFaculty of Medicine
-
- Funded by:
- Worldwide Cancer Research
